arrow
返回
S

Shu Wang

Peking University People's Hospital

32H指数
335论文数
3.7K被引数
收录论文 114
发表时间
AI-driven diffusion weighted imaging-based non-contrast protocol for breast cancer diagnosis: a multicentre, multidimensional validation study基于AI驱动的扩散加权成像的非对比剂乳腺癌症诊断方案:一项多中心、多维度的验证研究
err2025-12-05
err0
errOAAI
errYulu Liu; Haoquan Chen; Jiaqi Zhao; Lieji Wang; Zimei Gao; Yuan Peng; Wenhui Ren; Kaining Shi; Sen Zhang; Xiufeng Chen; Chenxin Pang; Manle Yan; Caizhen Feng; Fan Chai; Jin Gao; Xiaoxuan Jia; Shu Wang; Nan Hong; Yi Wang
err分享
err收藏
BVSim: A benchmarking variation simulator mimicking human variation spectrumBVSim:一个模拟人类变异谱的基准测试变异模拟器
err2025-08-30
err0
errOAAI
errYongyi Luo; Zhen Zhang; Shu Wang; Jiandong Shi; Jingyu Hao; Sheng Lian; Taobo Hu; Toyotaka Ishibashi; Depeng Wang; Weichuan Yu; Xiaodan Fan
err分享
err收藏
err分享
err收藏
Treg and intestinal myofibroblasts-derived Amphiregulin induced by TGF-β mediates intestinal fibrosis in Crohn's diseaseTreg和由TGF-β诱导的肠道肌成纤维细胞来源的Amphiregulin介导克罗恩病中的肠道纤维化
err2025-04-17
err0
errOAAI
errWang, Lu; Wang, Shu; Lin, Junjie; Li, Jiajia; Wang, Mingyuan; Yu, Jiang; Sun, Junjian; Tang, Nana; Jiao, Chunhua; Ma, Jingjing; Zhao, Xiaojing; Zhang, Hongjie
err分享
err收藏
Bireociclib plus fulvestrant for HR+/HER2-advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysisBirtociclib 联合 fulvestrant 治疗 HR+/HER2- 经内分泌治疗后进展的晚期女性乳腺癌:BRIGHT-2 研究 III 期中期分析
err2025-04-09
err0
errOAAI
errWang, Jiayu; Zhang, Qingyuan; Li, Huiping; Tong, Zhongsheng; Ouyang, Quchang; Li, Huihui; Teng, Yuee; Wang, Biyun; Sun, Tao; Wang, Jingfen; Li, Wei; Niu, Zhaofeng; Li, Hongsheng; Gong, Chang; Wang, Shu; Wang, Xinshuai; Wu, Xinhong; Liu, Ning; Yu, Guohua; Liu, Fei; Duan, Xianghui; Wang, Shuya; Meng, Yaping; Wang, Li
err分享
err收藏